Americans Are Optimistic About Coronavirus Vaccines
COVID-19 clinical trials are very important for both vaccines and medications
Most Americans are optimistic that advances to treat or prevent the coronavirus disease are on the horizon, saying they would get a vaccine if it were available, according to a Pew Research Center survey.
Published on May 21, 2020, this Pew survey was conducted between April 29 and May 5th and reported over 70 percent of Americans to expect to see a treatment or cure for COVID-19.
The Pew survey comes amid concerns that activists and others who are hesitant to get vaccinated for other diseases, such as measles, might not get inoculated against the coronavirus.
Majorities across demographic groups say they would get vaccinated for the coronavirus.
As an example, 74 percent of both Hispanic and white adults say they would get a vaccine if one were available.
The US Food and Drug Administration requires new treatments to go through a process of test runs – known as clinical trials – to establish that they are safe and effective in treating people with a specific disease.
In the new survey, about two-thirds of U.S. adults (64%) say the process of clinical trials is very important, “even if it will lengthen the time it takes to develop new treatments.”
Around three-in-ten (31%) say the clinical trial process is somewhat important, and just 5% say it is not too or not at all important.
A majority in the USA see the net benefits of allowing access to experimental drugs.
The new survey also asked Americans to consider the overall risks and benefits of access to experimental treatments before the completion of clinical trials.
Around six-in-ten Americans (59%) say the benefits of allowing more people to access experimental drugs outweigh the risks, while 40% say the risks outweigh the benefits.
Note: Here are the questions used for this report, along with responses.
Precision Vaccinations published coronavirus outbreak news.